Publications by authors named "Ann Thor"

Claim this Profile
T
Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer.
Reema S Wahdan-Alaswad, Susan M Edgerton, Hyun Min Kim, Aik Choon Tan, Bryan R Haugen, Ann D Thor

Cell Cycle· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel.
Hui Lyu, Fei Shen, Sanbao Ruan, Congcong Tan, Jundong Zhou, Ann D Thor

Cancer Cell Int· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in appointments to pathology department interim chair positions and subsequent advancement to permanent chair positions.
Mary F Lipscomb, Nancy E Joste, Madeleine Markwood, David N Bailey, Donna E Hansel, Ann Thor

Acad Pathol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer.
Elizabeth A Wellberg, Karen A Corleto, L Allyson Checkley, Sonali Jindal, Ginger Johnson, Ann D Thor

Breast Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC.
Shuang Liu, Erik V Polsdofer, Lukun Zhou, Sanbao Ruan, Hui Lyu, Ann D Thor

Mol Ther Oncolytics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers.
Reema S Wahdan-Alaswad, Susan M Edgerton, Hiba Salem, Hyun Min Kim, Aik Choon Tan, Ann D Thor

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HRHER2 breast cancer patients.
Adwitiya Kar, Karen Koto, Darius Walker, Tammy Trudeau, Susan Edgerton, Ann Thor

Breast Cancer Res Treat· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AIDS-related choroiditis.
Gregory S Canfield, Sarah Reingold, Andrea Ho, Ann D Thor, Paula E Pecen

IDCases· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem.
Reema Wahdan-Alaswad, Bolin Liu, Ann D Thor

Cancer Drug Resist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
Elizabeth A Wellberg, Peter Kabos, Austin E Gillen, Britta M Jacobsen, Heather M Brechbuhl, Ann D Thor

JCI Insight· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer.
Erin D Giles, Sonali Jindal, Elizabeth A Wellberg, Troy Schedin, Steven M Anderson, Ann D Thor

Breast Cancer Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells.
Harry Lee, Nipun Saini, Erin W Howard, Amanda B Parris, Zhikun Ma, Ann D Thor

Sci Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer.
Elizabeth A Wellberg, L Allyson Checkley, Erin D Giles, Stevi J Johnson, Robera Oljira, Ann D Thor

Horm Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
María J Contreras-Zárate, D Ryan Ormond, Austin E Gillen, Colton Hanna, Nicole L Day, Ann D Thor

Front Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells.
Ming Zhao, Erin W Howard, Amanda B Parris, Zhiying Guo, Qingxia Zhao, Ann D Thor

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression .
L Allyson Checkley, Michael C Rudolph, Elizabeth A Wellberg, Erin D Giles, Reema S Wahdan-Alaswad, Ann D Thor

Cancer Prev Res (Phila)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Reema Wahdan-Alaswad, J Chuck Harrell, Zeying Fan, Susan M Edgerton, Bolin Liu, Ann D Thor

Cell Cycle· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Hui Lyu, Jingcao Huang, Susan M Edgerton, Ann D Thor, Zhimin He

Int J Clin Exp Pathol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.
Hamid H Gari, Christy M Gearheart, Susan Fosmire, Gregory D DeGala, Zeying Fan, Ann D Thor

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells.
Hui Lyu, Xiao He Yang, Susan M Edgerton, Ann D Thor, Xiaoying Wu

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198).
Bryan P Schneider, Anne O'Neill, Fei Shen, George W Sledge, Ann D Thor

Br J Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in Workplace Satisfaction and Engagement of Academic Pathologists: Opportunities to Enhance Faculty Diversity.
Lydia Pleotis Howell, Mary Lipscomb Lyons, Ann Thor, Valerie Dandar

Arch Pathol Lab Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b.
Reema S Wahdan-Alaswad, Dawn R Cochrane, Nicole S Spoelstra, Erin N Howe, Susan M Edgerton, Ann D Thor

Horm Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling.
Sonali Jindal, Dexiang Gao, Pat Bell, Grethe Albrektsen, Susan M Edgerton, Ann D Thor

Breast Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Dawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, Diana M Cittelly, Erin N Howe, Ann D Thor

Breast Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis